Being lonely or socially isolated can negatively affect your wellbeing. There is even research showing that it increase the risk of illnesses such as cardiovascular disease, dementia and depression.
Some researchers suggest that loneliness and social isolation lead to poorer health because they increase inflammation. Inflammation is when your body tells your immune system to produce chemicals to fight off infection or injury. It can also occur when you experience psychological or social stress.
Short-term, local inflammation – such as when you accidentally cut your finger – can be helpful, but having slightly elevated long-term inflammation is associated with poor health. Researchers propose that loneliness and social isolation are linked to this elevated long-term inflammation.
In our latest study, we wanted to see if loneliness (the subjective state of feeling alone) and social isolation (the objective state of being alone) are linked to long-term inflammation. To do this, we searched for all published studies that looked at loneliness with inflammation or social isolation with inflammation. We found 14 studies that examined loneliness and 16 that examined social isolation.
Our analysis revealed that people who are more socially isolated have higher levels of two inflammatory chemicals: C-reactive protein and fibrinogen. C-reactive protein is commonly used as an indicator of inflammation and high levels are associated with poor health. Fibrinogen increases blood clotting and is higher when people have an injury or trauma. When people have long-term increased levels of these inflammatory markers, it can lead to an increased risk of poorer health over time.
An evolved response?
Social isolation could be linked to higher levels of inflammation for several reasons. It could be that social isolation leads to inflammation. We have evolved to be a social species, so being socially isolated could be a source of stress. And stress has a direct effect on the immune system.
It is also possible that we evolved to turn on our immune response when we are isolated. This is because when alone we could be at a greater risk of being injured. Our immune system may have learned to turn itself on to prepare for this greater risk.
It is also possible that inflammation leads to social isolation. People who are ill and have higher levels of inflammation can feel like they don’t want to be around other people. This could be because we have evolved to want to isolate ourselves so we don’t infect other people.
People who have lots of physical illnesses also have higher levels of inflammation. Those people who have lots of physical illnesses are sometimes not as able to get around and could become socially isolated because of this.
The evidence linking loneliness with inflammation was less convincing. We found some evidence that loneliness was linked to an inflammatory chemical called interleukin-6. But this was not a consistent finding and was based on only two studies. This suggests that there may not be a direct effect of loneliness on inflammation. Instead, loneliness may change how our body responds to stress. There is research showing that lonely people are more likely to have an enhanced inflammatory response to stress.
Bigger picture
Our study provides some evidence of a link between social isolation and inflammation. But we think that the link between loneliness and social isolation with poor health is a lot more complex than inflammation.
To best understand how loneliness and social isolation influence health we need to examine a range of biological, psychological and social risk factors, such as blood pressure, mental health, income and social support, as they are all associated with increased inflammation.
To best understand how loneliness and social isolation affect health we may need to think about a bigger picture beyond inflammation. This study provides us with a useful first step in understanding part of this bigger picture.


Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 



